Zentraxa

Biotechnology, Test and Measurement
Founded in 1/1/17
Bristol, Bristol, City of, United Kingdom
For Profit

About Zentraxa

Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existing bio-design limits imposed by conventional peptide synthesis, with one universal process.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: 6704
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 500000 GBP
  • Last Funding: None (Series A)
  • Funding Status: Early Stage Venture

Technology Stack

Zentraxa actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Test and Measurement

Headquarters: Bristol, Bristol, City of, United Kingdom